Spravato Nasal Spray Cost

FDA Approves ‘Spravato’ Nasal Spray

PopSugar · 11h

Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Managed Healthcare Executive · 1d

FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it more difficult to be treated by traditional oral antidepressants.

Hosted on MSN · 1d

FDA approves first nasal spray treatment for severe depression

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe depression. It is now the first-ever stand-alone therapy for treatment-resistant depression.

pharmaphorum2d

J&J’s Spravato for depression ‘should be much cheaper’

The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per 28 mg device and costs around $32,400 for a year’s treatment, says ICER.

Inquirer on MSN3d

Controlled drug Ketamine a lifeline for patients with severe depression in Singapore

SINGAPORE (The Straits Times/ANN): Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has ...

Johnson & Johnson Gets FDA OK For Spravato as Monotherapy

J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.

pharmaphorum7mon

NICE declines to look again at depression drug Spravato

The UK agency declined to recommend NHS funding for Spravato (esketamine) nasal spray in 2020 – following ... for the drug and believed it was not cost-effective. In a statement, J&J said ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results